Revenio Group Oyj · OMXHEX:REG1V
Revenio Group Oyj — Q1 2022 Earnings Presentation
15 slides from Revenio Group Oyj's earnings presentation, Apr 27, 2022
Slide 1: Strong start for the year driven by Europe and US
REVENIO GROUP: INTERIM REPORT Q1/2022 STRONG START FOR THE YEAR DRIVEN BY EUROPE AND US JOUNI TOIJALA, CEO ROBIN PULKKINEN, CFO April 28, 2022
Slide 2: Disclaimer
Disclaimer This presentation does not constitute an invitation to underwrite, subscribe for, or otherwise acquire or dispose of any Revenio's shares. Revenio’s past performance is no guide to future performance, and persons needing advice should consult an independent financial adviser. This present
Slide 3: We aspire to keep the wonderful world visible for all
We aspire to keep the wonderful world visible for all Jouni Toijala Robin Pulkkinen CEO CFO
Slide 4: Agenda
Agenda 1. Business highlights of the quarter 2. Financials and shareholders 3. Financial guidance
Slide 5: Highlights of the quarter
Highlights of the quarter Strong start for the year driven by Europe and US • Both of our product groups saw good demand, with very strong growth in sales of retinal imaging devices • Driven by the competitive positioning of devices, and our continued success in gaining market share • Demand was str
Slide 6: January – March 2022 highlights
January – March 2022 highlights Strong start for the year driven by Europe and US • Net sales totaled EUR 20.2 (16.8) million, an increase of 20.5% NET SALES 20.2 MEUR • The currency-adjusted growth of net sales in January– March was 17.1% + 20.5% • Operating profit was EUR 5.6 (4.6) million, or 27.
Slide 7: iCare ILLUME screening solution launched after the review period
iCare ILLUME screening solution launched after the review period We launched iCare ILLUME, a screening solution for the care pathway of diabetic retinopathy, after the reporting period. Patient images taken with the iCare DRSplus fundus imaging system are automatically transferred to our iCare ILLUM
Slide 8: Financials
FINANCIALS ROBIN PULKKINEN, CFO
Slide 9: Development of Revenio's key figures
Development of Revenio’s key figures MEUR Q1/2022 Q1/2021 Change-% • Net sales growth 20.5% in the quarter, and 17.1% in Net sales 20.2 16.8 20.5 comparable currencies Gross margin 14.7 12.0 22.1 Gross margin, % 72.6 71.7 1.0 • Favorable product mix, exchange rates and split EBITDA 6.4 5.3 21.0 betw
Slide 10: Q1 2022: Growth continued strong; net sales increased by 20.5%
Q1 2022: Growth continued strong; net sales increased by 20.5% Net sales (EUR million) Adjusted operating profit EUR million and % (EBIT) 25 23,8 1,2 8 7,6 7,4 45 38,8 19,7 20,2 7 35,2 30,7 40 18,9 19,4 1 5,9 20 5,6 31,3 5,6 35 16,8 6 5,2 23,7 31 15,8 0,8 25,2 27,5 30 15 13,7 5 4,5 11,9 25 0,6 4 20,
Slide 11: Strong balance sheet and cash flow to secure financial flexibility
Strong balance sheet and cash flow to secure financial flexibility Cash flow from operations (EUR million) Equity ratio and net gearing (%) 70 67,4 25 64,0 63 12 11,0 65 61,1 60,9 61,9 59,5 60,3 20,7 20 60 57,6 10 55 14,8 15 8 50 6,5 6,2 11,2 5,8 45 10 6 4,0 40 6,7 6,5 6,1 4 5 2,9 35 2 30 0,8 0 -0,3
Slide 12: Shareholders on March 31, 2022
Shareholders on March 31, 2022* No. of shares % Verified • Owner distribution by country: 1. William Dement Invest A/S 3,995,849 14.98% 2022-03-31 Finland 48.62% 2. Columbia Threadneedle 1,246,478 4.67% 2021-12-31 United States 16.84% 3. SEB Funds 1,215,663 4.56% 2022-03-31 Denmark 15.44% 4. Capital
Slide 13: Financial guidance
Financial guidance Net sales Financial guidance for 2022 Net sales (EUR million) Operating profit, EBIT (EUR million) 78,8 (published on February 10, 2022) 61,1 49,5 Revenio Group's exchange rate adjusted net sales are estimated to grow strongly from the previous year and 26,8 30,7 23,4 profitabilit
Slide 14: Q&A
Q&A REVENIO
Slide 15: We aspire to keep the wonderful world visible for all
“We aspire to keep the Financial guidance for 2021 – updated on August 4 , 2021 th wonderful world visible for all” Revenio Group’s exchange rate adjusted net sales are estimated to grow very strongly from the previous year and profitability is to remain at a good level without non-recurring items.